Medical News

RSS

Low doses of imatinib drug can push immune system to combat bacterial infections

Low doses of the anti-cancer drug imatinib can spur the bone marrow to produce more innate immune cells to fight against bacterial infections, Emory researchers have found.

1 Apr 2015

World-first human clinical trials for Hendra virus to begin this month

An antibody manufactured at The University of Queensland will be used in world-first human Hendra virus clinical trials starting this month.

1 Apr 2015

Scientists isolate energy-burning 'beige' fat from adult humans

For the first time, a research team, led by a UC San Francisco biologist, has isolated energy-burning "beige" fat from adult humans, which is known to be able to convert unhealthy white fat into healthy brown fat. The scientists also found new genetic markers of this beige fat.

1 Apr 2015

Some older people are diagnosed with cancer after emergency admission to hospital

People over 60 are at higher risk of being diagnosed with lung or bowel cancer as an emergency in hospital than younger people, according to a Cancer Research UK-supported report, published today by BMJ Open.

1 Apr 2015

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

McGraw-Hill Education, a leading global provider of content and services for the science, technical, and medical communities, announced the launch of the ObGyn Collection on AccessMedicine, the latest addition to the McGraw-Hill Education suite of comprehensive online resources for medical students, residents, and healthcare professionals.

1 Apr 2015

Screening people at risk of PTSD can help prevent further cases going unnoticed

When people have repeated non-specific health problems, it could be related to previous exposure to traumatic events. GPs may be seeing more patients with post-traumatic stress disorder (PTSD) as military personnel return from overseas deployments.

1 Apr 2015

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases today announced that data from the Company’s Phase 3 clinical trial of its pharmaceutical grade L-glutamine (PGLG) treatment for sickle cell anemia and sickle beta-0 thalassemia, will be presented, during the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting.

1 Apr 2015

New article highlights need for optimization of warfarin therapy

Warfarin can be a challenging drug to manage. Long-term anticoagulation is recommended for patients with atrial fibrillation at risk of stroke, and for those with recurrent venous thrombosis or prosthetic heart valves.

1 Apr 2015

Combined therapy boosts growth in short children with low IGF-1

Children with short stature benefit from receiving combined treatment with growth hormone and insulin-like growth factor-1, if they have low endogenous levels of the latter, a study shows.

1 Apr 2015

CVD risk assessment still important in severely obese adolescents

Researchers report a dose–response relationship between body mass index and cardiovascular risk even in severely obese adolescents, making its assessment important to limit further disease progression.

1 Apr 2015

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Paediatric patients with triiodothyronine-predominant Graves' disease develop severe disease that needs increased doses of antithyroid drugs, a study shows.

1 Apr 2015

Idiopathic central precocious puberty on the rise in boys

About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.

1 Apr 2015

Prolonged insulin therapy often unnecessary in children with Type 2 diabetes

Many children who require insulin treatment on diagnosis with Type 2 diabetes can be weaned off the medication, show findings from the run-in phase of the Treatment Options for Type 2 Diabetes in Adolescents and Youth study.

1 Apr 2015

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

NPS MedicineWise today launches a new learning program and health professional tools on the use of proton pump inhibitors (PPIs) in the treatment of uncomplicated gastro-oesophageal reflux disease (GORD).

1 Apr 2015

CABG surgery improves long-term survival in diabetic patients with severe heart disease

Among diabetic patients with severe heart disease, coronary artery bypass grafting (CABG) surgery is better than stenting (percutaneous coronary intervention; PCI) at improving long-term survival and reducing the risk of adverse complications, according to an article in the April 2015 issue of The Annals of Thoracic Surgery.

1 Apr 2015

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System.

From NanoString Technologies 1 Apr 2015

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BioMedical Enterprises announced the launch of the Speed Titan Nitinol Bone Fixation Implant today. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc and Speed Shift™ implants to create the world's most comprehensive family of continuous active compression Nitinol implants.

1 Apr 2015

Catasys' total revenues increase 169% to $2.0 million in 2014

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today reported full year 2014 financial results for the period ended December 31, 2014.

1 Apr 2015

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has entered into a partnership with American HealthCare Lending to provide funding for patient access to vBloc Therapy, delivered via the Maestro Rechargeable System, for the treatment of obesity.

1 Apr 2015

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

Pfizer Canada Inc., the distributor of EpiPen, and the Montreal Bell Centre are pleased to announce that EpiPen (epinephrine) emergency kits are now available at the Bell Centre, home of the Montreal Canadiens hockey team. The new partnership strives to offer a safeguarded environment for visitors at risk of serious allergic reactions during hockey games, concerts and other entertainment events.

1 Apr 2015

Medical News

Low doses of imatinib drug can push immune system to combat bacterial infections

World-first human clinical trials for Hendra virus to begin this month

Scientists isolate energy-burning 'beige' fat from adult humans

Some older people are diagnosed with cancer after emergency admission to hospital

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

Screening people at risk of PTSD can help prevent further cases going unnoticed

Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease

New article highlights need for optimization of warfarin therapy

Combined therapy boosts growth in short children with low IGF-1

CVD risk assessment still important in severely obese adolescents

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Idiopathic central precocious puberty on the rise in boys

Prolonged insulin therapy often unnecessary in children with Type 2 diabetes

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

CABG surgery improves long-term survival in diabetic patients with severe heart disease

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

Catasys' total revenues increase 169% to $2.0 million in 2014

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EpiPen (epinephrine) emergency kits now available at Montreal Bell Centre for treating severe allergies

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News